Koyfin Home > Directory > Health Care > Inovio Pharma > Repurchase of Common Stock

Inovio Pharma Repurchase of Common Stock Chart (INO)

Inovio Pharma annual/quarterly Repurchase of Common Stock from 2017 to 2020.
  • Inovio Pharma Repurchase of Common Stock for the quarter ending June 06, 2020 was $0m a -4,214.69% increase of 0m year over year
  • Inovio Pharma Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-2m a 59.23% decrease of -1m year over year
Other Cash Flow Metrics:
  • Inovio Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a 27.23% decrease of -5m year over year
  • Inovio Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-18m a 95.05% decrease of -17m year over year
  • Inovio Pharma Total Revenue for the quarter ending September 09, 2018 was $2m a -339.17% decrease of -7m year over year
View Chart On Koyfin

Quarterly INO Repurchase of Common Stock Data

06/2020$0m
03/2020$-2m
09/2019$0m
06/2019$0m
03/2019$-1m
03/2018$-1m
12/2017$0m

Annual INO Repurchase of Common Stock Data

2019$-1m